comparemela.com

Latest Breaking News On - Institutional trading of vertex pharmaceuticals - Page 1 : comparemela.com

Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Buy" at StockNews.com

StockNews.com downgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a report published on Monday. VRTX has been the subject of several other research reports. Royal Bank of Canada upped their price objective on shares of Vertex Pharmaceuticals from $417.00 to $424.00 and gave the stock […]

Canada
Sanfordc-bernstein
Brucei-sachs
William-blair
Charlesf-wagner-jr
News-ratings-for-vertex-pharmaceuticals-daily
Vertex-pharmaceuticals-price-performance
Wells-fargo-company
Norges-bank
Vertex-pharmaceuticals
Analyst-recommendations-for-vertex-pharmaceuticals
Jennison-associates

StockNews.com Upgrades Vertex Pharmaceuticals (NASDAQ:VRTX) to "Strong-Buy"

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Sunday. Other analysts have also issued reports about the stock. Canaccord Genuity Group reissued a “sell” rating and set a $371.00 target price on shares of Vertex […]

Ourania-tatsis
Sanfordc-bernstein
Investment-advisers
Vertex-pharmaceuticals-incorporated
Barclays
Institutional-trading-of-vertex-pharmaceuticals
Cantor-fitzgerald
Plato-investment-management-ltd
News-ratings-for-vertex-pharmaceuticals-daily
Montchanin-asset-management
Analyst-recommendations-for-vertex-pharmaceuticals
Canaccord-genuity-group

Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Buy" at StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Buy" at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Annapolis
Nova-scotia
Canada
Arlington
Texas
United-states
Ourania-tatsis
Amit-sachdev
Securities-exchange-commission
Fortitude-family-office
Institutional-trading-of-vertex-pharmaceuticals
Arlington-trust-co

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $466.00 by Analysts at UBS Group

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $466.00 by Analysts at UBS Group
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Ourania-tatsis
Stuarta-arbuckle
Securities-exchange-commission
Vertex-pharmaceuticals
Canaccord-genuity-group
Analyst-recommendations-for-vertex-pharmaceuticals
Institutional-trading-of-vertex-pharmaceuticals
Vertex-pharmaceuticals-company-profile
Cantor-fitzgerald
Vertex-pharmaceuticals-stock
Insider-activity-at-vertex-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.